An international group of experts convened to determine prescribing criteria equivalences that would be inclusionary of adults with Down syndrome. This advisory and consensus statement is the result of the experts’ deliberations and recommendations for addressing this inequity to treatment access and includes alternative inclusionary language and modified criteria, as well as providing a roadmap for prescribers when determining eligibility for adults with Down syndrome.
You can read more in our press release.
Source: LuMind IDSC Foundation and National Task Group on Intellectual Disabilties and Dementia Practices